MILAAN-(BUSINESS WIRE)- Deenova kondigde vandaag aan dat het zijn recordbrekende marktmomentum, gestart in 2021, behoudt door het winnen van concurrerende openbare aanbestedingen in Resah voor 6 D3 ACCED Robots en meerdere D3 Astus medicatie-oplossingen die 24 uur per dag zullen worden bediend in het Universitair Ziekenhuis van Nîmes, Centre Hospitalier Intercommunal Eaubonne Montmorency-Simone Veil in Sud Val d’Oise, en tot slot Centre Hospitalier Sainte-Marie Le Puy-en-Velay.

Christophe Jaffuel, Chief Commercial Officer van Deenova, verklaarde: “Ik ben erg trots dat Frankrijk twee jaar op rij de internationale groei van Deenova blijft leiden. De laatste 3 competitieve overwinningen van ons team benadrukken de belangrijkste onderscheidende kenmerken van Deenova ten opzichte van onze concurrentie, vooral in Frankrijk: patiëntenzorg ontworpen voor betere veiligheid en betere therapietrouw, evenals 24/7 beschikbaarheid, een belangrijk onderdeel van de behoeften van de klant ”.

Deenova Keeps Smashing New Sales Records in 2022 France’s Pharmacy Automation Market

MILAN–(BUSINESS WIRE)– Deenova announced today it keeps its record-breaking market momentum started in 2021, by winning competitive public tenders at Resah for 6 D3 ACCED Robots and multiple D3 Astus medication solutions to be operated around the clock at Nimes University Hospital, Centre Hospitalier Intercommunal Eaubonne Montmorency-Simone Veil in Sud Val d’Oise, and finally Centre Hospitalier Sainte-Marie Le Puy-en-Velay.

Christophe Jaffuel, Deenova Chief Commercial Officer, stated: “I am very proud France continues to lead Deenova’s international growth for 2 years in a row. Our team latest 3 competitive wins highlight Deenova main differentiating characteristics over our competition, especially in France: Patient Care Crafted for Better Safety and Greater Therapy Compliance, as well as 24/7 availability, a key component of customer needs”.

Loïc Bessin, Managing Director of Deenova in France stated: “I am delighted to welcome 3 new groups of hospital customers to the fast-growing Deenova family in Europe. It is indeed a huge milestone for our company and for our customers to witness first-hand the unparalleled and sustained recognition and success we are receiving over the last 2 years.”

Nimes University Hospital, founded in 1958, is a reference center of medical and surgical specialties, with the priorities of prevention, health education, access to care and fight against social exclusion.

Centre Hospitalier Intercommunal Eaubonne Montmorency-Simone Veil is a key public health player in the Val d’Oise Area with a diversified healthcare offer: medicine, surgery, residential facilities for dependent elderly people and a long-term care unit, psychiatric care, rehabilitation services, etc.

Centre Hospitalier Sainte-Marie Le Puy-en-Velay was created in 1850 by the nuns of the Congregation Sainte-Marie de L’Assomption de PRIVAS. The evolution of mental health care has led the hospital towards elderly, disabled adults and dependent people over the entire Haute-Loire, with home care services, therapeutic reception centers, mobile psychiatry, long-stay unit, etc.

Resah is a public interest group (GIP) created in 2007 to support the pooling of hospital purchases for the Ile-de-France region, in collaboration with Achat Hopital.

Deenova is the undisputed leading supplier of mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere.

Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.

Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210505005485/en/

Contacts

Contacts at Deenova:

Martina Buccianti, +39 0523 785311

Christophe Jaffuel